ACM
EBS icon

Aquatic Capital Management’s Emergent Biosolutions EBS Stock Holding History

Aquatic Capital Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-55,646
Closed -$462K – 1378
2026
Q1 		$462K Buy
55,646
+26,895
+94% +$279K 0.01% 779
2025
Q4 		$355K Buy
28,751
+18,119
+170% +$194K 0.01% 836
2025
Q3 		$93.8K Sell
10,632
-4,472
-30% -$34.8K ﹤0.01% 1226
2025
Q2 		$96.4K Buy
15,104
+14,698
+3,620% +$84.1K ﹤0.01% 1094
2025
Q1 		$1.97K Sell
406
-22,665
-98% -$188K ﹤0.01% 1207
2024
Q4 		$221K Buy
23,071
+9,571
+71% +$87.8K 0.01% 910
2024
Q3 		$113K Buy
+13,500
New +$123K ﹤0.01% 910
2023
Q2 		– Sell
-1,900
Closed -$20K – 1442
2023
Q1 		$20K Sell
1,900
-400
-17% -$4.83K ﹤0.01% 1052
2022
Q4 		$27K Sell
2,300
-14,200
-86% -$220K ﹤0.01% 1122
2022
Q3 		$346K Buy
+16,500
New +$459K 0.03% 493
2022
Q2 		– Sell
-100
Closed -$4K – 1286
2022
Q1 		$4K Buy
+100
New +$4.41K 0.01% 859

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Aquatic Capital Management's EBS Position: Q2 2026 in Review

Aquatic Capital Management sold out of Emergent Biosolutions (EBS) in Q2 2026, closing a stake of 55,646 shares — an estimated $462K sold.

Aquatic Capital Management first reported a position in EBS in Q1 2022 and held it in 11 quarters. The position peaked at $462K in Q1 2026. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Aquatic Capital Management reported no remaining Emergent Biosolutions position as of Q2 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 55,646 Emergent Biosolutions shares in Q2 2026, an estimated $462K.
  • Aquatic Capital Management first reported a position in Emergent Biosolutions in Q1 2022 and held it in 11 quarters.
  • Aquatic Capital Management's Emergent Biosolutions position peaked at $462K in Q1 2026.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.